Drug Trial Radar · NCT04588129
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: May 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Jan 5, 2021
Primary completion
Sep 17, 2021
Study completion Nov 15, 2021
Sponsor
- Lead sponsor
- LB Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Washington University School of Medicine
- First posted
- Oct 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open label study in 4 cohort of 4 healthy volunteers each designed to evaluate the dopamine receptor occupancy of LB-102 at various doses and timepoints.
Conditions
- Schizophrenia
Interventions
LB-102Drug
(N-Methyl amisulpride)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Brain Receptor Occupancy as Measured by Positron Emission TomographyTime frame: 2.5 hours post LB-102 dose
- Brain Receptor Occupancy as Measured by Positron Emission TomographyTime frame: 7.5 hours post LB-102 dose
- Brain Receptor Occupancy as Measured by Positron Emission TomographyTime frame: 23.5 hours post LB-102 dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Washington University School of Medicine
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.